This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Hospital Clinic De Barcelona, Advanced Marker Discovery, S.l., Centro De Investigacion Biomedica En Red. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021-2026
Title: Innovations of Antoni Castells Garangou
Introduction
Antoni Castells Garangou is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the identification of pancreatic cancer. His innovative approach has the potential to improve early detection and treatment outcomes for patients at risk.
Latest Patents
Antoni Castells Garangou holds a patent for an in vitro method for identifying pancreatic cancer or intraductal papillary mucinous neoplasm of the pancreas. This invention involves measuring the expression pattern or level of specific microRNAs obtained from isolated biological samples. The method compares these levels to established patterns, where overexpression of certain microRNAs indicates the presence of pancreatic cancer or IPMN.
Career Highlights
Throughout his career, Antoni has worked with various organizations, including Advanced Marker Discovery, S.L. and Centro de Investigación Biomédica en Red. His work has focused on advancing the understanding of cancer diagnostics and improving patient care through innovative methodologies.
Collaborations
Antoni has collaborated with notable professionals in his field, including Meritxel Gironella Cos and Marta Herreros Villanueva. These collaborations have contributed to the development and refinement of his innovative diagnostic methods.
Conclusion
Antoni Castells Garangou's contributions to medical diagnostics, particularly in pancreatic cancer detection, highlight the importance of innovation in healthcare. His work exemplifies how targeted research and collaboration can lead to significant advancements in patient diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile